JWH 073 5-hydroxyindole metabolite-d7 – 500 µg

Brand:
Cayman
CAS:
1630022-99-9
Storage:
-20
UN-No:
De Minimis - 1648 / 3

JWH 073 5-hydroxyindole metabolite-d7 contains seven deuterium atoms at the 2, 2’, 3, 3’, 4, 4, and 4 positions. It is intended for use as an internal standard for the quantification of JWH 073 5-hydroxyindole metabolite by GC- or LC-mass spectrometry (MS). JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 5-hydroxyindole metabolite is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}  

 

Available on backorder

SKU: 10718 - 500 µg Category:

Description

An internal standard for the quantification of JWH 073 5-hydroxyindole metabolite by GC- or LC-MS


Formal name: (1-butyl-2,2,3,3,4,4,4-d7-5-hydroxy-1H-indol-3-yl)(naphthalen-1-yl)-methanone

Synonyms: 

Molecular weight: 350.5

CAS: 1630022-99-9

Purity: ≥99% deuterated forms (d1-d7)

Formulation: A solution in acetonitrile


Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Drugs of Abuse||Product Type|Biochemicals|Isotopically Labeled Standards|Deuterium||Research Area|Forensic Chemistry & Toxicology|Cannabinoids|Synthetic Cannabinoids